Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Testosterone: Functions and Regulation

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Signs of Puberty

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Hormones of the Adrenal Glands

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...

Intracellular Hormone Receptors

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Weight Loss Directly Influences Intermediate-Term Remission of Diabetes Mellitus After Bariatric Surgery: A Retrospective Case-Control Study.

Obesity surgery·2019

Same author

Clomiphene citrate effect on testosterone level and semen parameters in 18 infertile men with low testosterone level and normal/low gonadotropines level.

European journal of obstetrics, gynecology, and reproductive biology·2019

Same author

The production of glial cell line-derived neurotrophic factor by human sertoli cells is substantially reduced in sertoli cell-only testes.

Human reproduction (Oxford, England)·2017

Same author

Impact of the reduction of the recommended energy target in the ICU on protein delivery and clinical outcomes.

Clinical nutrition (Edinburgh, Scotland)·2016

Same author

[DXA imaging: the multifunction Swiss army knife?].

Revue medicale suisse·2015

Same author

Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient.

European journal of clinical nutrition·2014

Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026

Same journal

[Integrative medicine : a structured referral framework for general practitioners].

Revue medicale suisse·2026

Same journal

[Targeted therapy for ultra-rare diseases].

Revue medicale suisse·2026

Same journal

[Inherited metabolic diseases in adults : from diagnosis to treatment].

Revue medicale suisse·2026

Same journal

[Cardiogenetics in clinical practice : challenges, indications, and perspectives].

Revue medicale suisse·2026

Same journal

[Genetic medicine illustrated by three key syndromes].

Revue medicale suisse·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 26, 2026

Murine Prostate Micro-dissection and Surgical Castration

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

[Testosterone and prostate].

L Vaucher¹, D A Paduch, P Jichlinski

¹Service d'urologie, CHUV, 1011 Lausanne. laurent.vaucher@chuv.ch

Revue Medicale Suisse

|January 12, 2012

Summary

This summary is machine-generated.

Testosterone replacement therapy is not linked to increased prostate cancer incidence or worsened urinary symptoms in hypogonadal men. Restoring testosterone to normal levels appears safe for prostate health in elderly men.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

Related Experiment Videos

Last Updated: May 26, 2026

Murine Prostate Micro-dissection and Surgical Castration

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

Area of Science:

Endocrinology and Urology
Geriatric Medicine

Context:

Age-related testosterone deficiency (hypogonadism) is common in elderly men and often co-occurs with prostate diseases.
The use of testosterone replacement therapy (TRT) has increased, prompting research into its effects on the prostate.
Previous concerns linked testosterone administration to prostate cancer growth, but recent evidence challenges this notion.

Purpose:

To evaluate the impact of testosterone replacement therapy on prostate health in hypogonadal men.
To assess the relationship between physiological testosterone levels and prostate cancer incidence.
To determine if TRT exacerbates lower urinary tract symptoms in aging men with testosterone deficiency.

Summary:

Current evidence does not support the hypothesis that testosterone administration promotes prostate cancer.
Restoring testosterone levels within the physiological range in hypogonadal patients has not been shown to increase prostate cancer incidence.
Testosterone replacement therapy does not appear to worsen lower urinary tract symptoms in men with hypogonadism.

Impact:

Challenges traditional beliefs regarding testosterone's role in prostate cancer development.
Provides evidence supporting the safety of TRT for prostate health in hypogonadal men.
Informs clinical practice regarding the management of testosterone deficiency in elderly men with prostate conditions.